Farms.com Home   Ag Industry News

Reflecting on the first outdoor farm show

Reflecting on the first outdoor farm show

Jack Bonham remembers attending the first one almost 25 years ago

By Diego Flammini
News Reporter
Farms.com

2017 marks the 24th anniversary of Canada’s Outdoor Farm Show, but there couldn’t be 24 farm shows if there wasn’t a first one.

And a select few, like 91-year-old Jack Bonham with JB Enterprises, can recall the atmosphere around the first outdoor farm show more than two decades ago.

“(The first outdoor show was in 1994) in Burford (Ont.),” he told Farms.com today. “That’s where (the late Ginty Jocius) started. It was really a good show. A lot of people showed up because they’d never been to any outdoor show before. I was quite surprised at how many people we did get (into the show).”

Bonham has attended every show since the first one and is impressed with its growth.

“(The show) has kept growing bigger and bigger,” he said. “I would say it’s at least three times the size of what it was when we first started. The new farm equipment has (also) really grown.”

 


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.